Transcatheter aortic valve implantation - Amended items

This page provides information on changes to three Medicare Benefits Schedule (MBS) transcatheter aortic valve implantation (TAVI) items 38495, 38514 and 38522 from 1 January 2024.

Page last updated: 22 December 2023

From 1 January 2024, three Medicare Benefits Schedule (MBS) TAVI items 38495, 38514 and 38522 will be amended to include the additional wording ‘includes valvuloplasty, if required’.

This will mean that valvuloplasty can no longer be co-claimed with these procedures. The balloon valvuloplasty service performed under MBS item 38270 is inherent to the TAVI procedure and therefore should not be co claimed with TAVI items for the same occasion of service.

PDF Version - Amended items for transcatheter aortic valve implantation (PDF 153 KB)
Word Version - Amended items for transcatheter aortic valve implantation (Word 120 KB)

In this section